as well as existing investors Longview Ventures, Rev1 Ventures, and The Ohio State University. UK biotech Enterprise Therapeutics has closed a £26 million ($33 million) Series B follow-on round ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback